$PGNX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PROGENICS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PROGENICS PHARMACEUTICALS INC. Get notifications about new insider transactions in PROGENICS PHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Das Asha | Chief Medical Offic ... | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Das Asha | Chief Medical Offic ... | Option Exercise | D | 4.56 | 125,000 | 570,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Das Asha | Chief Medical Offic ... | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Das Asha | Chief Medical Offic ... | Option Exercise | D | 4.56 | 125,000 | 570,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 6.62 | 100,000 | 662,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Sell | D | 0.00 | 21,202 | 0 | 0 | 21.2 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Option Exercise | D | 6.62 | 100,000 | 662,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | COO | Sell | D | 0.00 | 21,202 | 0 | 0 | 21.2 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 6.62 | 75,900 | 502,458 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 11.32 | 66,000 | 747,120 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 6.62 | 75,900 | 502,458 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 6.77 | 75,000 | 507,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 11.32 | 66,000 | 747,120 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | D | 6.77 | 75,000 | 507,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.77 | 82,214 | 392,161 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 6.62 | 94,875 | 628,073 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.52 | 90,750 | 410,190 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 11.32 | 82,500 | 933,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 6.62 | 94,875 | 628,073 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.52 | 82,500 | 372,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 11.32 | 82,500 | 933,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 6.65 | 66,000 | 438,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.52 | 82,500 | 372,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.70 | 75,000 | 352,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 6.65 | 66,000 | 438,900 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.70 | 52,800 | 248,160 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.70 | 75,000 | 352,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 5.03 | 48,000 | 241,440 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.70 | 52,800 | 248,160 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 9.81 | 40,000 | 392,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 5.03 | 48,000 | 241,440 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 7.40 | 60,000 | 444,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 9.81 | 40,000 | 392,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.83 | 25,000 | 120,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 7.40 | 60,000 | 444,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 5.35 | 6,000 | 32,100 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 4.83 | 25,000 | 120,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Sell | D | 0.00 | 4,121 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | D | 5.35 | 6,000 | 32,100 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Mims David W. | Interim CEO and Int ... | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Sell | D | 0.00 | 4,121 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Mims David W. | Interim CEO and Int ... | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Mims David W. | Interim CEO and Int ... | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Mims David W. | Interim CEO and Int ... | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Sell | D | 0.00 | 50,000 | 0 | 0 | 50 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Director | Sell | D | 0.00 | 50,000 | 0 | 0 | 50 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 4.89 | 28,000 | 136,920 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Sell | D | 0.00 | 12,000 | 0 | 0 | 12 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Option Exercise | D | 4.89 | 28,000 | 136,920 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Director | Sell | D | 0.00 | 12,000 | 0 | 0 | 12 K to 0 (-100.00 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.89 | 20,000 | 97,800 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.72 | 20,000 | 134,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.89 | 20,000 | 97,800 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.47 | 20,000 | 89,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.72 | 20,000 | 134,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.50 | 40,000 | 180,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.47 | 20,000 | 89,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.50 | 40,000 | 180,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | MacDougall Ann L. | Director | Option Exercise | D | 5.01 | 36,065 | 180,686 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | MacDougall Ann L. | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | MacDougall Ann L. | Director | Option Exercise | D | 5.01 | 36,065 | 180,686 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | MacDougall Ann L. | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Maeusli Heinz Christoph | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Maeusli Heinz Christoph | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | Maeusli Heinz Christoph | Option Exercise | A | 5.01 | 16,393 | 82,129 | 16,393 | ||
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | Maeusli Heinz Christoph | Option Exercise | A | 5.01 | 40,000 | 200,400 | 40,000 | ||
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | Mims David W. | Option Exercise | A | 5.01 | 16,393 | 82,129 | 16,393 | ||
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | Mims David W. | Option Exercise | A | 5.01 | 40,000 | 200,400 | 40,000 | ||
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | MacDougall Ann L. | Option Exercise | A | 5.01 | 36,065 | 180,686 | 36,065 | ||
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | MacDougall Ann L. | Option Exercise | A | 5.01 | 40,000 | 200,400 | 40,000 | ||
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Option Exercise | A | 5.01 | 16,393 | 82,129 | 16,393 | ||
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Option Exercise | A | 5.01 | 40,000 | 200,400 | 40,000 | ||
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Option Exercise | A | 5.01 | 16,393 | 82,129 | 16,393 | ||
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | Ber Gerard | Option Exercise | A | 5.01 | 40,000 | 200,400 | 40,000 | ||
| Sep 11 2019 | PGNX | PROGENICS PHARMACE ... | Velan Capital, L.P. | 10% Owner | Buy | P | 4.99 | 72,023 | 359,733 | 8,011,733 | 7.9 M to 8 M (+0.91 %) |
| Sep 09 2019 | PGNX | PROGENICS PHARMACE ... | LTE Partners, LLC | 10% Owner | Buy | P | 4.94 | 21,480 | 106,096 | 1,950,000 | 1.9 M to 2 M (+1.11 %) |
| Sep 09 2019 | PGNX | PROGENICS PHARMACE ... | LTE Partners, LLC | 10% Owner | Buy | P | 4.62 | 43,520 | 201,097 | 1,928,520 | 1.9 M to 1.9 M (+2.31 %) |
| Sep 05 2019 | PGNX | PROGENICS PHARMACE ... | Velan Capital, L.P. | 10% Owner | Buy | P | 4.51 | 243,614 | 1,098,529 | 7,939,710 | 7.7 M to 7.9 M (+3.17 %) |
| Sep 05 2019 | PGNX | PROGENICS PHARMACE ... | Velan Capital, L.P. | 10% Owner | Buy | P | 4.39 | 277,424 | 1,218,918 | 7,696,096 | 7.4 M to 7.7 M (+3.74 %) |
| Sep 05 2019 | PGNX | PROGENICS PHARMACE ... | Velan Capital, L.P. | 10% Owner | Buy | P | 4.51 | 243,614 | 1,098,529 | 7,939,710 | 7.7 M to 7.9 M (+3.17 %) |
| Sep 05 2019 | PGNX | PROGENICS PHARMACE ... | Velan Capital, L.P. | 10% Owner | Buy | P | 4.39 | 277,424 | 1,218,918 | 7,696,096 | 7.4 M to 7.7 M (+3.74 %) |
| Aug 27 2019 | PGNX | PROGENICS PHARMACE ... | Velan Capital, L.P. | 10% Owner | Buy | P | 4.30 | 73,230 | 314,911 | 7,418,672 | 7.3 M to 7.4 M (+1.00 %) |
| Aug 27 2019 | PGNX | PROGENICS PHARMACE ... | Velan Capital, L.P. | 10% Owner | Buy | P | 4.31 | 130,826 | 563,690 | 7,345,442 | 7.2 M to 7.3 M (+1.81 %) |
| Jul 15 2019 | PGNX | PROGENICS PHARMACE ... | WILLIAMS NICOLE | Option Exercise | A | 5.74 | 25,000 | 143,500 | 25,000 | ||
| Jul 15 2019 | PGNX | PROGENICS PHARMACE ... | SCHEINBERG DAVID A | Option Exercise | A | 5.74 | 25,000 | 143,500 | 25,000 | ||
| Jul 15 2019 | PGNX | PROGENICS PHARMACE ... | KISHBAUCH MICHAEL D | Option Exercise | A | 5.74 | 25,000 | 143,500 | 25,000 | ||
| Jul 15 2019 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Option Exercise | A | 5.74 | 25,000 | 143,500 | 25,000 | ||
| Jul 15 2019 | PGNX | PROGENICS PHARMACE ... | Crowley Peter J | Option Exercise | A | 5.74 | 55,000 | 315,700 | 55,000 | ||
| Jul 15 2019 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Option Exercise | A | 5.74 | 25,000 | 143,500 | 25,000 | ||
| Jul 08 2019 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Option Exercise | M | 4.89 | 12,000 | 58,680 | 0 | ||
| Jul 08 2019 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Buy | M | 4.89 | 12,000 | 58,680 | 12,000 | 0 to 12 K | |
| Jul 03 2019 | PGNX | PROGENICS PHARMACE ... | SCHEINBERG DAVID A | Option Exercise | M | 5.33 | 10,000 | 53,300 | 0 | ||
| Jul 03 2019 | PGNX | PROGENICS PHARMACE ... | SCHEINBERG DAVID A | Buy | M | 5.33 | 10,000 | 53,300 | 56,185 | 46.2 K to 56.2 K (+21.65 %) | |
| Jun 27 2019 | PGNX | PROGENICS PHARMACE ... | Crowley Peter J | Option Exercise | M | 5.33 | 10,000 | 53,300 | 0 | ||
| Jun 27 2019 | PGNX | PROGENICS PHARMACE ... | Crowley Peter J | Option Exercise | M | 5.33 | 10,000 | 53,300 | 0 | ||
| Jun 27 2019 | PGNX | PROGENICS PHARMACE ... | Crowley Peter J | Option Exercise | M | 5.35 | 40,000 | 214,000 | 0 | ||
| Jun 27 2019 | PGNX | PROGENICS PHARMACE ... | Crowley Peter J | Option Exercise | M | 5.35 | 40,000 | 214,000 | 0 | ||
| Jun 27 2019 | PGNX | PROGENICS PHARMACE ... | Crowley Peter J | Buy | M | 5.35 | 40,000 | 214,000 | 50,000 | 10 K to 50 K (+400.00 %) | |
| Jun 27 2019 | PGNX | PROGENICS PHARMACE ... | Crowley Peter J | Buy | M | 5.35 | 40,000 | 214,000 | 50,000 | 10 K to 50 K (+400.00 %) | |
| Jun 27 2019 | PGNX | PROGENICS PHARMACE ... | Crowley Peter J | Buy | M | 5.33 | 10,000 | 53,300 | 10,000 | 0 to 10 K | |
| Jun 27 2019 | PGNX | PROGENICS PHARMACE ... | Crowley Peter J | Buy | M | 5.33 | 10,000 | 53,300 | 10,000 | 0 to 10 K | |
| Mar 05 2019 | PGNX | PROGENICS PHARMACE ... | Fabbio Patrick | CFO | Option Exercise | A | 4.52 | 90,750 | 410,190 | 90,750 | |
| Mar 05 2019 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | A | 4.52 | 90,750 | 410,190 | 90,750 | |
| Mar 05 2019 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | A | 4.52 | 90,750 | 410,190 | 90,750 | |
| Mar 05 2019 | PGNX | PROGENICS PHARMACE ... | Baker Mark Robert | Chief Executive Off ... | Option Exercise | A | 4.52 | 192,500 | 870,100 | 192,500 | |
| Feb 05 2019 | PGNX | PROGENICS PHARMACE ... | Das Asha | Chief Medical Offic ... | Option Exercise | A | 4.56 | 125,000 | 570,000 | 125,000 | |
| Jun 14 2018 | PGNX | PROGENICS PHARMACE ... | WILLIAMS NICOLE | Option Exercise | A | 8.99 | 25,000 | 224,750 | 25,000 | ||
| Jun 14 2018 | PGNX | PROGENICS PHARMACE ... | SCHEINBERG DAVID A | Option Exercise | A | 8.99 | 25,000 | 224,750 | 25,000 | ||
| Jun 14 2018 | PGNX | PROGENICS PHARMACE ... | KISHBAUCH MICHAEL D | Option Exercise | A | 8.99 | 25,000 | 224,750 | 25,000 | ||
| Jun 14 2018 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Option Exercise | A | 8.99 | 25,000 | 224,750 | 25,000 | ||
| Jun 14 2018 | PGNX | PROGENICS PHARMACE ... | Crowley Peter J | Option Exercise | A | 8.99 | 55,000 | 494,450 | 55,000 | ||
| Jun 14 2018 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Option Exercise | A | 8.99 | 25,000 | 224,750 | 25,000 | ||
| Mar 02 2018 | PGNX | PROGENICS PHARMACE ... | Osorio Benedict | Senior Vice Preside ... | Option Exercise | A | 6.62 | 100,000 | 662,000 | 100,000 | |
| Mar 02 2018 | PGNX | PROGENICS PHARMACE ... | Wong Vivien | EVP, Development | Option Exercise | A | 6.62 | 94,875 | 628,073 | 94,875 | |
| Mar 02 2018 | PGNX | PROGENICS PHARMACE ... | Summer Jeffery | SVP, Digital Techno ... | Option Exercise | A | 6.62 | 94,875 | 628,073 | 94,875 | |
| Mar 02 2018 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | A | 6.62 | 75,900 | 502,458 | 75,900 | |
| Mar 02 2018 | PGNX | PROGENICS PHARMACE ... | Tenbarge Bryce | SVP, Commercial | Option Exercise | A | 6.62 | 75,900 | 502,458 | 75,900 | |
| Mar 02 2018 | PGNX | PROGENICS PHARMACE ... | Fabbio Patrick | CFO | Option Exercise | A | 6.62 | 94,875 | 628,073 | 94,875 | |
| Mar 02 2018 | PGNX | PROGENICS PHARMACE ... | Baker Mark Robert | Chief Executive Off ... | Option Exercise | A | 6.62 | 201,250 | 1,332,275 | 201,250 | |
| Jun 15 2017 | PGNX | PROGENICS PHARMACE ... | Campbell Bradley L | Option Exercise | A | 6.95 | 20,000 | 139,000 | 20,000 |